FAIR LAWN, N.J.--(BUSINESS WIRE)--Vyteris, Inc. (OTCBB: VYHN), manufacturer of LidoSite®, the first active transdermal patch approved by the U.S. Food and Drug Administration for the pain associated with blood draws (venipuncture), IV (intravenous) cannulations and laser ablation of superficial skin lesions, today announced the appointment Rafael Espinal as its new vice president of manufacturing, in a move to significantly deepen its management team for manufacturing and production.
